T lymphocyte recruitment into renal cell carcinoma tissue: A role for chemokine receptors CXCR3, CXCR6, CCR5, and CCR6

European Urology

Volumn 61, Issue 2, 2012, Pages 385-394

  Oldham, Kimberley A ^a   Parsonage, Greg ^a   Bhatt, Rupesh I ^b   Wallace, D Michael A ^b   Deshmukh, Nayneeta ^b   Chaudhri, Shalini ^b   Adams, David H ^a   Lee, Steven P ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Chemokine receptors; Immunotherapy; Renal cell carcinoma; Tumour infiltrating lymphocytes

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR6; CXCL11 CHEMOKINE; CXCL16 CHEMOKINE; CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; RANTES; TRANSCRIPTION FACTOR FOXP3;

ADULT; AGED; ARTICLE; CANCER TISSUE; CONTROLLED STUDY; EFFECTOR CELL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; KIDNEY CARCINOMA; LYMPHOCYTE MIGRATION; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TUMOR IMMUNITY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; CELL MOVEMENT; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; KIDNEY NEOPLASMS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MIDDLE AGED; RECEPTORS, CCR5; RECEPTORS, CCR6; RECEPTORS, CHEMOKINE; RECEPTORS, CXCR3; RECEPTORS, VIRUS; T-LYMPHOCYTES;

EID: 83955163746     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2011.10.035     Document Type: Article

References (32)

1. S.A. Rosenberg Interleukin 2 for patients with renal cancer Nat Clin Pract Oncol 4 2007 497
2. R. Childs, A. Chernoff, and N. Contentin Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation N Engl J Med 343 2000 750 758
3. Y. Takahashi, N. Harashima, and S. Kajigaya Regression of human kidney cancer following allogeneic stem cell transplantation is associated with recognition of an HERV-E antigen by T cells J Clin Invest 118 2008 1099 1109
4. K. Hanada, Q.J. Wang, T. Inozume, and J.C. Yang Molecular identification of an MHC-independent ligand recognized by a human {alpha}/{beta} T-cell receptor Blood 117 2011 4816 4825
5. M. Leisegang, A. Turqueti-Neves, and B. Engels T-cell receptor gene-modified T cells with shared renal cell carcinoma specificity for adoptive T-cell therapy Clin Cancer Res 16 2010 2333 2343
6. R.M. Snow, and P.F. Schellhammer Spontaneous regression of metastatic renal cell carcinoma Urology 20 1982 177 181
7. S.A. Rosenberg, N.P. Restifo, J.C. Yang, R.A. Morgan, and M.E. Dudley Adoptive cell transfer: a clinical path to effective cancer immunotherapy Nat Rev Cancer 8 2008 299 308
8. T.J. Curiel, G. Coukos, and L. Zou Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival Nat Med 10 2004 942 949
9. W. Zou Regulatory T cells, tumour immunity and immunotherapy Nat Rev Immunol 6 2006 295 307
10. F. Liotta, M. Gacci, and F. Frosali Frequency of regulatory T cells in peripheral blood and in tumour-infiltrating lymphocytes correlates with poor prognosis in renal cell carcinoma BJU Int 107 2011 1500 1506
11. R.W. Griffiths, E. Elkord, and D.E. Gilham Frequency of regulatory T cells in renal cell carcinoma patients and investigation of correlation with survival Cancer Immunol Immunother 56 2007 1743 1753
12. H.K. Jensen, F. Donskov, M. Nordsmark, N. Marcussen, and H. von der Maase Increased intratumoral FOXP3-positive regulatory immune cells during interleukin-2 treatment in metastatic renal cell carcinoma Clin Cancer Res 15 2009 1052 1058
13. K. Ley, C. Laudanna, M.I. Cybulsky, and S. Nourshargh Getting to the site of inflammation: the leukocyte adhesion cascade updated Nat Rev Immunol 7 2007 678 689
14. L. Machado, R. Jarrett, and S. Morgan Expression and function of T cell homing molecules in Hodgkin's lymphoma Cancer Immunol Immunother 58 2009 85 94
15. J. Wang, A. Ioan-Facsinay, E.I. van der Voort, T.W. Huizinga, and R.E. Toes Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells Eur J Immunol 37 2007 129 138
16. M. Ahmadzadeh, A. Felipe-Silva, and B. Heemskerk FOXP3 expression accurately defines the population of intratumoral regulatory T cells that selectively accumulate in metastatic melanoma lesions Blood 112 2008 4953 4960
17. I. Kryczek, R. Liu, and G. Wang FOXP3 defines regulatory T cells in human tumor and autoimmune disease Cancer Res 69 2009 3995 4000
18. J.M. Cozar, J. Canton, and M. Tallada Analysis of NK cells and chemokine receptors in tumor infiltrating CD4 T lymphocytes in human renal carcinomas Cancer Immunol Immunother 54 2005 858 866
19. S. Attig, J. Hennenlotter, and G. Pawelec Simultaneous infiltration of polyfunctional effector and suppressor T cells into renal cell carcinomas Cancer Res 69 2009 8412 8419
20. T. Kondo, H. Nakazawa, and F. Ito Favorable prognosis of renal cell carcinoma with increased expression of chemokines associated with a Th1-type immune response Cancer Sci 97 2006 780 786
21. R. Bonecchi, G. Bianchi, and P.P. Bordignon Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s J Exp Med 187 1998 129 134
22. T. Kondo, F. Ito, H. Nakazawa, S. Horita, Y. Osaka, and H. Toma High expression of chemokine gene as a favorable prognostic factor in renal cell carcinoma J Urol 171 2004 2171 2175
23. J.M. Romero, N. Aptsiauri, and F. Vazquez Analysis of the expression of HLA class I, proinflammatory cytokines and chemokines in primary tumors from patients with localized and metastatic renal cell carcinoma Tissue Antigens 68 2006 303 310
24. T. Suyama, M. Furuya, and M. Nishiyama Up-regulation of the interferon gamma (IFN-gamma)-inducible chemokines IFN-inducible T-cell alpha chemoattractant and monokine induced by IFN-gamma and of their receptor CXC receptor 3 in human renal cell carcinoma Cancer 103 2005 258 267
25. C.S. Tannenbaum, R. Tubbs, D. Armstrong, J.H. Finke, R.M. Bukowski, and T.A. Hamilton The CXC chemokines IP-10 and Mig are necessary for IL-12-mediated regression of the mouse RENCA tumor J Immunol 161 1998 927 932
26. P. Gutwein, A. Schramme, and N. Sinke Tumoural CXCL16 expression is a novel prognostic marker of longer survival times in renal cell cancer patients Eur J Cancer 45 2009 478 489
27. P. Middel, S. Brauneck, W. Meyer, and H.J. Radzun Chemokine-mediated distribution of dendritic cell subsets in renal cell carcinoma BMC Cancer 10 2010 578
28. J.E. Turner, H.J. Paust, and O.M. Steinmetz CCR6 recruits regulatory T cells and Th17 cells to the kidney in glomerulonephritis J Am Soc Nephrol 21 2010 974 985
29. L. Xu, W. Xu, S. Qiu, and S. Xiong Enrichment of CCR6 + Foxp3 + regulatory T cells in the tumor mass correlates with impaired CD8+ T cell function and poor prognosis of breast cancer Clin Immunol 135 2010 466 475
30. M.H. Kershaw, G. Wang, and J.A. Westwood Redirecting migration of T cells to chemokine secreted from tumors by genetic modification with CXCR2 Hum Gene Ther 13 2002 1971 1980
31. I.M. Desar, J.F.M. Jacobs, and C.A. Hulsbergen-vandeKaa Sorafenib reduces the percentage of tumour infiltrating regulatory T cells in renal cell carcinoma patients Int J Cancer 129 2011 507 512
32. O. Adotevi, H. Pere, and P. Ravel A decrease of regulatory T cells correlates with overall survival after sunitinib-based antiangiogenic therapy in metastatic renal cancer patients J Immunother 33 2010 991 998